watch $gns $slrx $nflx $hlbz LONG AND STRONG $VTVT *News about the start of TTP399 phase 3 any day from now When it finally happens after many years the stock will skyrocket

$SLRX SP-3164 showed significant tumor growth "inhibition" in in vivo studies including statistically significant improvement over the approved immunomodulatory drugs lenalidomide (Revlimid®) and pomalidomide (Pomalyst®)

At 🌋 phase.

$BBAI They have to factor in the jobs report which was excellent as well, it means that AI isn't going to phase out a key aspect of the economy.

It reported positive outcomes in pleural mesothelioma patients, including: Improved survival: Study patients lived around 11 months.

PROC data are excellent compared to any combo trials.

But yesterdays paper also has me considering, if there isn't a deal with $mrk or $BMY or some other CPI BP --- That data is Best In Class - best in clinic, best in trial too.

phase II results within weeks!!!

Now phase 3 trial is showing similar results to date where patients are living longer after Galinpepimut-S up to 1.5 year longer is a breakthrough for AML patients.

Positive trial data/results supported with bullish news and sentiment! 4.

The nation’s best means the O'Neal Comprehensive Center in Alabama have access to the latest therapies, cutting-edge clinical trials and the expertise needed to treat their cancer.

Gps is doing what it has done in every single trial and its the reason Patients are living 3 fold longer than patients on best available treatments.

Treatment with GFH009 resulted in 90 to 100 percent cancer inhibition at dose levels equivalent to those already demonstrated to be safe in patients in the ongoing Phase 1 trial with no viable cancer cells at the highest dose levels.